Everolimus in combination with octreotide LAR as the first-line treatment for advanced neuroendocrine tumors: efficacy data in pNET and non-pNET patients: ITMO (Italian Trials in Medical Oncology) group
EUROPEAN JOURNAL OF CANCER（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要